A shorter course of pulmonary rehabilitation, with phone support, improved symptoms and reduced hospital readmissions for patients with post-acute exacerbation in chronic obstructive pulmonary disease (AECOPD).
The health burden of comorbid chronic obstructive pulmonary disease (COPD) and asthma is known to be greater than when either condition exists on its own. An upcoming study shows that COPD is linked with greater all-cause mortality and greater risk of mortality in patients with coexisting asthma who also had long-term use of corticosteroids.
Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.
Lung cancer screening by low-dose computed tomography does not examine spirometry in eligible patients, but study findings published this week suggest that adding this feature could improve the high burden of undiagnosed chronic obstructive pulmonary disease (COPD) and emphysema.
The investigators conducted the study to understand more about the influence of each predictive factor of mortality in chronic obstructive pulmonary disease (COPD), as rates of death from the pulmonary disease have risen worldwide.